Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2007
11/22/2007US20070270436 Novel amino- and imino-alkylpiperazines
11/22/2007US20070270407 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070269373 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo.
11/22/2007US20070269368 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; low molecular weight compounds; non-immunogenic
11/22/2007US20070267464 Cyclic hydrofluoroether compounds and processes for their preparation and use
11/22/2007CA2649708A1 Crystalline form of atorvastatin calcium stable after storage
11/22/2007CA2647238A1 2,4-diamino pyrimidines as cell cycle kinase inhibitors
11/21/2007EP1857455A1 Cinnamoyl compound and use thereof
11/21/2007EP1857442A2 Novel antimycobacterial compounds
11/21/2007EP1857113A2 Method and materials for treating asthma
11/21/2007EP1857104A1 Use of cinnamoyl compound
11/21/2007EP1856112A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/21/2007EP1856110A1 Oxyindole derivatives as 5ht4 receptor agonists
11/21/2007EP1856109A1 Novell processes for the preparation of a benzofuran
11/21/2007EP1856108A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions
11/21/2007EP1856107A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists
11/21/2007EP1856106A1 Novel processes for the preparation of a 2h-chromene
11/21/2007EP1856099A2 Acridine and quinoline derivatives as sirtuin modulators
11/21/2007EP1856098A2 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/21/2007EP1856097A2 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/21/2007EP1856083A2 Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
11/21/2007EP1856082A1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
11/21/2007EP1856049A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/21/2007EP1856048A1 Biphenyl compounds useful as muscarinic receptor antagonists
11/21/2007EP1856042A2 Substituted gamma lactams as therapeutic agents
11/21/2007EP1855670A2 Benzazole potentiators of metabotropic glutamate receptors
11/21/2007EP1761524B1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists
11/21/2007EP1663982B1 Aminoquinoline derivatives and their use as adenosine a3 ligands
11/21/2007EP1578425B1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/21/2007EP1572653B1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants
11/21/2007EP1474139B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007CN101074228A Method for preparing medicine composition containing 1,3-oxathin cyclopentane nucleoside analogues
11/21/2007CN100349913C 2'-fluoronucleosides
11/21/2007CN100349889C Substituted benzoyl derivatives as herbicides
11/21/2007CN100349888C Medicine compound
11/21/2007CN100349874C Novel compounds
11/20/2007US7297802 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides
11/20/2007US7297797 5-(2,6-difluorophenyl)-2-[4'-(5-ethoxy-2-thienyl)-1,1'-biphenyl-4-yl]-3,4-dihydro-2H-pyrrole; pesticide
11/20/2007US7297795 Process for preparation of 4-amino-3-quinolinecarbonitriles
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007US7297714 Inhibitors of cathepsin S
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297694 central nervous system disorders; traumas; anticancer agents; neurodegenerative agents; analgesics; headaches and cardiovascular disorders
11/20/2007US7297693 furan-, pyrrole- or thiophenecarboxamides ring-substituted with a hydroxyimino-fused ring and a nitrogen heteroarene; e.g., 5-[5-(1-Morpholin-4-yl-methanoyl)-2-pyridin-4-yl-furan-3-yl]-indan-1-one oxime;treating neurotraumatic diseases, cancer, neurodegeneration, pain, migraine and cardiac hypertrophy
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297325 Hydrophilic light absorbing compositions for determination of physiological function
11/20/2007CA2139374C Polyaminated ligands and metal complexes thereof
11/20/2007CA2125236C Fungicidal optically active 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
11/15/2007WO2007131153A2 Methods for the preparation of pyrazole-containing compounds
11/15/2007WO2007128874A1 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
11/15/2007WO2007128752A1 Pyridyl compounds
11/15/2007WO2007128694A1 N-oxides of pyridylmethylpiperazine and -piperidine derivatives
11/15/2007WO2007128454A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof
11/15/2007WO2007128086A2 Novel viral replication inhibitor
11/15/2007WO2007109578A3 Substituted gamma lactams as prostaglandin ep2 agonists
11/15/2007WO2007107384A3 Soluble adenylate cyclase inhibitors
11/15/2007WO2007076160A3 C-10 carbamates of taxanes
11/15/2007WO2007076092A3 Nitrogen- containing bicyclic hetroaryl compounds for the treatment of raf protein kinase-mediated diseases
11/15/2007WO2007067836A3 Substituted pyrazole compounds useful as soluble epoxide hydrolase inhibitors
11/15/2007WO2007067416A3 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
11/15/2007WO2007034270A3 Improved process for the preparation of (-) trans-n-methyl paroxetine
11/15/2007US20070265446 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
11/15/2007US20070265331 Such as (2S)-2-(3(S)-Acetylamino-3-((S)-sec-butyl)-2-oxo-pyrrolidin-1-yl)-N-[(1S,2R)-1-(3,5-difluoro-benzyl)-2-hydroxy-3-(3-methoxy-benzylamino)-propyl]-4-phenyl-butyramide; inhibit processing of amyloid precursor proteins
11/15/2007US20070265327 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
11/15/2007US20070265320 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
11/15/2007US20070265310 Biphenyl compounds useful as muscarinic receptor antagonists
11/15/2007US20070265302 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
11/15/2007US20070265280 Methods of using sodium channel blockers
11/15/2007US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists
11/15/2007US20070265263 Heterocyclic inhibitors of ERK2 and uses thereof
11/15/2007US20070265261 Dpp-IV Inhibitors
11/15/2007US20070265260 Quinazoline derivatives
11/15/2007US20070265228 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
11/15/2007US20070264333 Method of treatment
11/15/2007CA2654540A1 Histone deacetylase and tubulin deacetylase inhibitors
11/15/2007CA2651556A1 3-tetrazolylindazoles and 3-tetrazolylpyrazolopyridines and their use
11/15/2007CA2649479A1 N-oxides of pyridylmethylpiperazine and -piperidine derivatives
11/14/2007EP1854789A1 Quinazoline derivative having tyrosine kinase inhibitory activity
11/14/2007EP1854784A1 Activator for peroxisome proliferator activating receptor
11/14/2007EP1853593A1 Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride
11/14/2007EP1853592A1 Synthesis of himbacine analogs
11/14/2007EP1853583A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/14/2007EP1853558A1 Process for producing atorvastatin hemicalcium
11/14/2007EP1853269A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
11/14/2007EP1689231A4 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
11/14/2007EP1578745B1 BENZOFURAN DERIVATivES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES THEREOF
11/14/2007EP1565442B1 Pyridine derivatives as cb2 receptor modulators
11/14/2007EP1495018B1 Tricyclic thrombin receptor antagonists
11/14/2007EP1483262B1 Coumarines useful as biomarkers
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1399423B1 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
11/14/2007CN101072773A Pyrrole derivatives having CRTH2 receptor antagonist activity
11/14/2007CN101072772A 凝血酶受体拮抗剂 Thrombin receptor antagonists
11/14/2007CN101072759A Triazole compounds that modulate hsp90 activity
11/14/2007CN101072755A Pyridyl inhibitors of hedgehog signalling
11/14/2007CN101072563A Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
11/14/2007CN101072561A Diaminoalkane aspartic protease inhibitors
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 694